日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

US Food and Drug Administration Approval Summary: Imetelstat for Selected Patients With Low- to Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia

美国食品药品监督管理局批准摘要：伊美替司他用于治疗部分低危至中危-1型骨髓增生异常综合征伴输血依赖性贫血患者

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-01369
Kim, Nina; Pulte, E Dianne; Ehrlich, Lori A; Ionan, Alexei C; Haupert, Spencer; Vallejo, Jonathon; Green, Francis; Zheng, Nan; Wang, Yun; Liu, Jiang; Blanco, Javier G; Dorff, Sarah E; Booth, Brian; Choe, Moran; Gehrke, Brenda; Bhatnagar, Vishal; Theoret, Marc; Pazdur, Richard; De Claro, R Angelo; Norsworthy, Kelly J
贫血
代谢
发表日期：2025
文献求助 收藏

FDA Approval Summary: Asciminib for Ph+ CML in Chronic Phase Treated with Two or More Tyrosine Kinase Inhibitors and for the T315I Mutation

FDA批准摘要：Asciminib用于治疗接受过两种或两种以上酪氨酸激酶抑制剂治疗的慢性期Ph+ CML以及携带T315I突变的CML

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-1086
Pamuk, Gulsum E; Chow, Edwin C Y; Ionan, Alexei C; Chen, Haiyan; Lee, Shwu-Luan; Hsu, Vicky; Grimstein, Manuela; Zheng, Nan; Sun, Jielin; Charlab, Rosane; Gehrke, Brenda J; Vallejo, Jonathon; Ehrlich, Lori A; de Claro, R Angelo; Theoret, Marc R
信号转导
发表日期：2024
文献求助 收藏

Bayesian Methods in Human Drug and Biological Products Development in CDER and CBER

CDER 和 CBER 中贝叶斯方法在人类药物和生物制品开发中的应用

期刊:
影响因子:
doi:10.1007/s43441-022-00483-0
Ionan, Alexei C; Clark, Jennifer; Travis, James; Amatya, Anup; Scott, John; Smith, James P; Chattopadhyay, Somesh; Salerno, Mary Jo; Rothmann, Mark
Human
发表日期：2023
文献求助 收藏

Comparison of confidence interval methods for an intra-class correlation coefficient (ICC)

组内相关系数（ICC）置信区间方法的比较

期刊:BMC Medical Research Methodology
影响因子:3.4
doi:10.1186/1471-2288-14-121
Ionan, Alexei C; Polley, Mei-Yin C; McShane, Lisa M; Dobbin, Kevin K
发表日期：2014
文献求助 收藏